These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 1445360)

  • 21. Inhibiting long chain fatty Acyl CoA synthetase increases basal and agonist-stimulated NO synthesis in endothelium.
    Weis MT; Crumley JL; Young LH; Stallone JN
    Cardiovasc Res; 2004 Aug; 63(2):338-46. PubMed ID: 15249192
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evidence that increasing the cellular content of eicosapentaenoic acid does not reduce the biosynthesis of platelet-activating factor.
    Triggiani M; Connell TR; Chilton FH
    J Immunol; 1990 Oct; 145(7):2241-8. PubMed ID: 2118931
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Involvement of platelet-activating factor in endotoxin-induced priming of rabbit polymorphonuclear leukocytes.
    Stewart AG; Harris T
    J Lipid Mediat; 1991; 3(2):125-38. PubMed ID: 1665713
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inhibiting long-chain fatty acyl CoA synthetase does not increase agonist-induced release of arachidonate metabolites from human endothelial cells.
    Weis MT; Brady M; Moore M; Crumley J; Stallone JN
    J Vasc Res; 2005; 42(4):275-83. PubMed ID: 15908751
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evidence for an essential role of long chain acyl-CoA synthetase in animal cell proliferation. Inhibition of long chain acyl-CoA synthetase by triacsins caused inhibition of Raji cell proliferation.
    Tomoda H; Igarashi K; Cyong JC; Omura S
    J Biol Chem; 1991 Mar; 266(7):4214-9. PubMed ID: 1999415
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Synergistic effect of thromboxane A2 and N-formylmethionylleucylphenylalanine on platelet-activating factor synthesis in human polymorphonuclear neutrophils.
    Kishino J; Hanasaki K; Kato T; Arita H
    Biochim Biophys Acta; 1991 Apr; 1092(2):169-74. PubMed ID: 1673352
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Complete inhibition of mouse macrophage-derived foam cell formation by triacsin C.
    Namatame I; Tomoda H; Arai H; Inoue K; Omura S
    J Biochem; 1999 Feb; 125(2):319-27. PubMed ID: 9990129
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Differential responsiveness of human neutrophils to the autocrine actions of 1-O-alkyl-homologs and 1-acyl analogs of platelet-activating factor.
    Pinckard RN; Showell HJ; Castillo R; Lear C; Breslow R; McManus LM; Woodard DS; Ludwig JC
    J Immunol; 1992 Jun; 148(11):3528-35. PubMed ID: 1316919
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A sensitive and specific radioimmunoassay for platelet-activating factor.
    Wang C; Tai HH
    Lipids; 1992 Mar; 27(3):206-8. PubMed ID: 1522765
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Characterization of triacsin C inhibition of short-, medium-, and long-chain fatty acid: CoA ligases of human liver.
    Vessey DA; Kelley M; Warren RS
    J Biochem Mol Toxicol; 2004; 18(2):100-6. PubMed ID: 15122652
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Influence of isoproterenol and phosphodiesterase inhibitors on platelet-activating factor biosynthesis in the human neutrophil.
    Fonteh AN; Winkler JD; Torphy TJ; Heravi J; Undem BJ; Chilton FH
    J Immunol; 1993 Jul; 151(1):339-50. PubMed ID: 8392098
    [TBL] [Abstract][Full Text] [Related]  

  • 32. 1-Acyl-2-acetyl-sn-glycero-3-phosphocholine from stimulated human polymorphonuclear leukocytes.
    Satouchi K; Oda M; Saito K
    Lipids; 1987 Apr; 22(4):285-7. PubMed ID: 3110532
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Triacsin C blocks de novo synthesis of glycerolipids and cholesterol esters but not recycling of fatty acid into phospholipid: evidence for functionally separate pools of acyl-CoA.
    Igal RA; Wang P; Coleman RA
    Biochem J; 1997 Jun; 324 ( Pt 2)(Pt 2):529-34. PubMed ID: 9182714
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Differential actions of diacyl- and alkylacylglycerols in priming phospholipase A2, 5-lipoxygenase and acetyltransferase activation in human neutrophils.
    Bauldry SA; Wykle RL; Bass DA
    Biochim Biophys Acta; 1991 Jul; 1084(2):178-84. PubMed ID: 1854803
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Alkyl-PAF and acyl-PAF human neutrophil priming for enhanced fMLP- and rC5a-induced superoxide anion production.
    Pinckard RN; Prihoda TJ
    J Leukoc Biol; 1996 Feb; 59(2):219-28. PubMed ID: 8603994
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Human intestinal acyl-CoA synthetase 5 is sensitive to the inhibitor triacsin C.
    Kaemmerer E; Peuscher A; Reinartz A; Liedtke C; Weiskirchen R; Kopitz J; Gassler N
    World J Gastroenterol; 2011 Nov; 17(44):4883-9. PubMed ID: 22171129
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Enhancement by staurosporine of platelet-activating factor formation in N-formyl peptide-challenged human neutrophils is mediated by intracellular platelet-activating factor binding sites.
    Müller S; Nigam S
    Biochem Biophys Res Commun; 1992 Dec; 189(2):771-6. PubMed ID: 1335246
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Downregulation of leptin by free fatty acids in rat adipocytes: effects of triacsin C, palmitate, and 2-bromopalmitate.
    Shintani M; Nishimura H; Yonemitsu S; Masuzaki H; Ogawa Y; Hosoda K; Inoue G; Yoshimasa Y; Nakao K
    Metabolism; 2000 Mar; 49(3):326-30. PubMed ID: 10726909
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Regulation of platelet-activating factor (PAF) biosynthesis via coenzyme A-independent transacylase in the macrophage cell line IC-21 stimulated with lipopolysaccharide.
    Svetlov SI; Liu H; Chao W; Olson MS
    Biochim Biophys Acta; 1997 Jun; 1346(2):120-30. PubMed ID: 9219895
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Platelet-activating factor production in human neutrophils by sequential stimulation with granulocyte-macrophage colony-stimulating factor and the chemotactic factors C5A or formyl-methionyl-leucyl-phenylalanine.
    Wirthmueller U; De Weck AL; Dahinden CA
    J Immunol; 1989 May; 142(9):3213-8. PubMed ID: 2540238
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.